• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GermanyChange country/region
Pulmonology

Klaus Rabe

MD, PhD, FERS

Professor of Pulmonary Medicine | University of Kiel; Director of the Department of Pneumology | LungClinic Grosshansdorf, Kiel, Germany

Klaus Rabe

Biography

Klaus F. Rabe, MD, PhD, FERS, is Professor of Pulmonary Medicine at the University of Kiel and Director of the Department of Pneumology, LungClinic Grosshansdorf, Germany. 

Prof. Rabe is a Fellow and Past President of the European Respiratory Society and currently serves as Vice Chairman of the German Center for Lung Research. He is the Past President of the German Chest Society, and a member of the British Pharmacological Society and the American Thoracic Society. He has served on committees for the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease. 

Prof. Rabe serves on the editorial board of several journals including the American Journal of Respiratory and Critical Care Medicine and is past Chief Editor of the European Respiratory Journal. He received several distinctions including the Balzan award in 2019. 

Prof. Rabe has been active in various fields of respiratory medicine worldwide. His current scientific interests are related to large clinical trials in COPD and asthma, the mechanisms of airway inflammation, and early determinants of lung health. Prof. Rabe has been involved in many major COPD trials, including the pivotal studies on phosphodiesterase inhibitors and biologics for asthma and COPD.  

ADVENT contributions by this expert

ERS 2024 | Understanding the Complex Pathophysiology of COPD
Pulmonology
6 min
expert video

ERS 2024 | Understanding the Complex Pathophysiology of COPD

What Are the Key Inflammatory Processes in Patients with COPD?
Pulmonology
2 min
expert video

What Are the Key Inflammatory Processes in Patients with COPD?

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
Pulmonology
78 min
expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
Type 2 Inflammation
46 min
expert video

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video

ERS 2024 | IL-33 A Promising Target
Pulmonology
7 min
expert video

ERS 2024 | IL-33 A Promising Target

ERS 2024 | Targeting IL-33 in COPD: Exploring  New Frontiers for COPD  Management
Pulmonology
45 min
expert video

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

ERS 2024 | Fireside Chat: What Is the Potential for Disease Modification in the Era of Biologics?
Pulmonology
12 min
expert video

ERS 2024 | Fireside Chat: What Is the Potential for Disease Modification in the Era of Biologics?

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?
Pulmonology
30 min
expert video

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology
Pulmonology
17 min
expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology
Pulmonology
9 min
expert video

ERS 2023 | Contextualizing Clinical Presentation of COPD Through Disease Pathology

2025 ADVENT Forum | Potential for Disease Modification in the Airway
Type 2 Inflammation
45 min
expert video

2025 ADVENT Forum | Potential for Disease Modification in the Airway